プロフィール詳細

プロジェクトを作成

★★★★★

☆☆☆☆☆

★★★★★

☆☆☆☆☆

Dr. Shrinidh J.に依頼

Canada

PhD in Pharmaceutical Science with 15+ years of experience in Pharmaceutical - Clinical - Regulatory- Medical Devices

プロフィール概要

I am an agile, performance-driven and critical problem solver scientist with a passion for scientific, pharmaceutical, medical devices, and strategic consulting, disseminating strategic, streamlined and value-driven disease state education that is patient-centric. I am passionate about bringing a scientific approach to the assigned work and manage the projects within timeline. I am also inherently curious with business acumen and passionate about enhancing practice excellence to improve patient health outcomes by parsing insights and disseminating emerging clinical data through tailored clinical education. I am having 13+ years of scientific experience in clinical research, medical and regulatory writing, editing and manuscript writing. Scientific Consultant/Medical writer - Biotechnology - Healthcare - Life Sciences Research Professional - BioPharma Consulting I have over 13 years of life science/ biotech experience (regenerative medicine and multiple therapeutic area research background), in and out of the lab, at North Dakota State University, University Health Network, Krembil Research Institute, Sun Pharma, Virgilant, CannTrust and ThermoFisher Scientific. I am consulting for a number of ongoing R&D projects including projects on formulation development, regulatory affairs, patents and medical affairs. I launched ACE2STEM during my PhD which aspires to cure diabetic vascular disease using the patient's own stem cells. I have a strong understanding of the pharmaceutical-biologics market; antibodies, regenerative medicine, cell, and gene therapy, viral products, cancer immunotherapy, Mesenchymal stromal cells and Bioreactors, Medical devices, Scaffolds, Cannabinoids, and its formulations. I have written a number of whitepapers, and a book chapter within the sector, as well as first author research publications from my time in the lab. My Pubmed profile: https://www.ncbi.nlm.nih.gov/pubmed/?term=shrinidh+joshi my ORCiD profile: https://orcid.org/0000-0001-5406-2256 Shrinidh Joshi, PhD Research & Development, Scientific writer, Analysis - Creating Value Based on Innovation

専門分野

• ★ Medical Devices
• ★ Clinical Trials
• ☆ Regulatory Affairs
• ☆ Immunotherapy
• ☆ Medical Writing

サービス

• Writing
• Research
• Consulting
• Data & AI
• Product Development

Writing Clinical Trial Documentation, Technical Writing, Newswriting

Research Market Research, Feasibility Study, Fact Checking, Gray Literature Search, Systematic Literature Review, Secondary Data Collection

Consulting Scientific and Technical Consulting

Data & AI Statistical Analysis

Product Development Formulation

職務経験

Technical Project Leader II

ThermoFisher Scientific

11月 2019 - 現在

Technical Project Leader II

Thermo Fisher Scientific

11月 2019 - 現在

University Health Network

1月 2019 - 11月 2019

Research Assistant

North Dakota State University

1月 2014 - 4月 2019

Research Officer

Sun Pharma Advanced Research (India)

7月 2009 - 12月 2013

学歴

MBA

Quantic School of Business and Technology

3月 2021 - 現在

Doctor of Philosophy (PhD)

North Dakota State University

1月 2014 - 12月 2018

MS in Pharmaceutical Sciences

The M S University of Baroda

7月 2007 - 6月 2009

BS in Pharmacy

Veer Narmad South Gujarat University

9月 2003 - 6月 2007

認定資格

• 認定資格の詳細は未入力です。

出版物

JOURNAL ARTICLE

(2020). Blood Flow Restriction Exercise Stimulates Mobilization of Hematopoietic Stem/Progenitor Cells and Increases the Circulating ACE2 Levels in Healthy adults . Journal of applied physiology (Bethesda, Md. : 1985).

(2019). Hypoxic regulation of angiotensin‐converting enzyme 2 and Mas receptor in human CD34 + cells . Journal of Cellular Physiology.

(2018). Mitochondrial depolarization stimulates vascular repair-relevant functions of CD34⁺ cells via reactive oxygen species-induced nitric oxide generation . British Journal of Pharmacology.

(2017). Reversal of bone marrow mobilopathy and enhanced vascular repair by angiotensin-(1-7) in Diabetes . Diabetes. 66. (2). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 505-518.

(2016). Angiotensin converting enzyme versus angiotensin converting enzyme-2 selectivity of MLN-4760 and DX600 in human and murine bone marrow-derived cells . European Journal of Pharmacology. 774. Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 25-33.

Singh, N., Joshi, S., Guo, L., Singh, N., Joshi, S., Guo, L., Baker, M.B., Li, Y., Castellano, R.K., Raizada, M.K., et al.(2015). ACE2/Ang-(1-7)/Mas axis stimulates vascular repair-relevant functions of CD34⁺ cells . American Journal of Physiology - Heart and Circulatory Physiology. 309. (10). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString H1697-H1707.

Joshi, S.A., Chavhan, S.S., Sawant, K.K.(2010). Rivastigmine-loaded PLGA and PBCA nanoparticles: Preparation, optimization, characterization, in vitro and pharmacodynamic studies . European Journal of Pharmaceutics and Biopharmaceutics. 76. (2). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 189-199.